Evotec SE (OTCMKTS:EVTCY – Get Free Report)’s share price hit a new 52-week low on Monday . The company traded as low as $7.23 and last traded at $7.25, with a volume of 36469 shares changing hands. The stock had previously closed at $7.29.
Evotec Trading Down 3.3 %
The firm has a market capitalization of $2.31 billion, a PE ratio of 17.68 and a beta of 0.98. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53. The stock’s fifty day simple moving average is $7.42 and its 200 day simple moving average is $8.81.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- Investing in large cap stocks: Diving into big caps
- United Airlines Soars on Earnings Beat
- Ride Out The Recession With These Dividend Kings
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
